NCT02985216 is a Phase 3 clinical trial of YHD1119 in Peripheral Neuropathic Pain, sponsored by Yuhan Corporation.

Who is sponsoring NCT02985216?

NCT02985216 is sponsored by Yuhan Corporation.

What drugs are being tested in NCT02985216?

Interventions in NCT02985216: YHD1119, Lyrica.

What condition does NCT02985216 study?

NCT02985216 studies Peripheral Neuropathic Pain.

Is NCT02985216 still recruiting?

NCT02985216 is currently completed. Last updated 16 January 2019.

Last reviewed 2019-01-16 · How we verify

NCT02985216

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain

Completed Phase 3 Last updated 16 January 2019

What this trial tests

Phase 3 trial testing YHD1119 in Peripheral Neuropathic Pain in 371 participants. Completed in 2 May 2018.

Timeline

7 February 2017

Primary endpoint
27 April 2018

2 May 2018

Quick facts

Lead sponsor	Yuhan Corporation
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	371
Start date	7 February 2017
Primary completion	27 April 2018
Estimated completion	2 May 2018
Sites	1 location across South Korea

Drugs / interventions tested

YHD1119 — full drug profile →
Lyrica (Pregabalin) — full drug profile →

Conditions studied

Peripheral Neuropathic Pain — all drugs for Peripheral Neuropathic Pain →

Sponsor

Yuhan Corporation — full company profile →

Who can join

Adults 19 to 80, any sex, with Peripheral Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Randomized, Double-blind, Active-Controlled, Multi-center, Phase 3 Trial to Compare the Safety and Efficacy between YHD1119 and Pregabalin in Patients with Peripheral Neuropathic Pain

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials.
Huerta MÁ, Garcia MM, García-Parra B, Serrano-Afonso A, et al · · 2023 · cited 20× · PMID 37629168 · DOI 10.3390/ijms241612987
Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial.
Han KA, Lee YH, Son HS, Song KH, et al · · 2022 · cited 7× · PMID 35220330 · DOI 10.1097/ajp.0000000000001028

Verify or expand the search:

Other recruiting trials for Peripheral Neuropathic Pain

Currently open trials in the same condition.

NCT07160049 — Wearable Focused Ultrasound Stimulation for Peripheral Nerve Pain Management · NA · active not recruiting
NCT06964243 — Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain · NA · recruiting
NCT05817591 — Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or W · recruiting
NCT05351801 — Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain · Phase 2 · recruiting
NCT06290661 — Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pai · NA · recruiting

Other Yuhan Corporation trials

Trials by the same sponsor.

NCT07470125 — Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers · Phase 1 · not yet recruiting
NCT07415551 — Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1- · Phase 2 · recruiting
NCT07265167 — Bioequivalence Study Between YHP2406 and YHR2501 in Healthy Subjects · Phase 1 · completed
NCT07111468 — Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis · Phase 3 · completed
NCT06920719 — Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02985216 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yuhan Corporation
Last refreshed: 16 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02985216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing